Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06VFO
|
||||
Former ID |
DNAP001613
|
||||
Drug Name |
Anisodamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Central and peripheral nervous diseases [ICD10:G96.9] | Approved | [551871] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H23NO4
|
||||
Canonical SMILES |
CN1C2CC(CC1C(C2)O)OC(=O)C(CO)C3=CC=CC=C3
|
||||
InChI |
1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13+,14-,15+,16+/m1/s1
|
||||
InChIKey |
WTQYWNWRJNXDEG-LEOABGAYSA-N
|
||||
CAS Number |
CAS 55869-99-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Beta-1 adrenergic receptor | Target Info | Modulator | [533488] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.